The best way to beat persistent inflation is to invest in businesses unaffected by rising prices, like these four high-yield ...

The IQVIA Institute for Human Data Science Study has developed a specific forecast for these new biosimilar molecules in oncology. The majority of the savings will be from three top-selling ...

In accordance with the biosimilar guidelines of NMPA ... a diversified and high-quality product pipeline covering over 50 molecules and has continued to explore immuno-oncology combination ...

Nandita Vijayasimha, Bengaluru Wednesday, February 19, 2025, 08:00 Hrs [IST] ...

Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...

Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...

Sarfaraz K. Niazi, PhD, gives his opinion on how the recent IQVIA report “Assessing the Biosimilar Void in the US” could be ...

Biosimilars and biobetters present a lucrative ... have to follow the principles and guidelines as applicable for new molecules. However, there is a potential to refer to publically available ...

As clinical trial complexity, duration, and cost continue to rise, life sciences companies are turning to data to help them ...

(Reuters) - Amgen posted a higher quarterly profit on Tuesday as product sales rose 11% and said late-stage studies of key ...

15 fév 2025 Samsung Bioepis Gains European Commission (EC) Approval for Denosumab Biosimilar (OBODENCEtm ... global biopharmaceutical company focused on developing differentiated molecules and ...